Results 81 to 90 of about 6,785 (193)

Patientendaten künftig direkt an MDK [PDF]

open access: yesDNP - Der Neurologe und Psychiater, 2015
Bis die Ubermittlung der Patientendaten endlich elektronisch laufen kann, ist doch wenigstens einmal noch der bisherige Postweg aus Sicherheitsgrunden zu modifizieren.
openaire   +2 more sources

Midkine (MDK) in Hepatocellular Carcinoma: More than a Biomarker

open access: yesCells
Midkine (MDK) is a multifunctional secreted protein that can act as a cytokine or growth factor regulating multiple signaling pathways and being implicated in fundamental cellular processes, such as survival, proliferation, and migration.
Christiana Christou   +2 more
doaj   +1 more source

566 MDK-202: An empirically-designed peptidyl agonist of the IL-2/15βγc receptor, devoid of Rα interaction, unrelated to IL-2 or IL-15, and fused to an Fc-domain for PK enhancement

open access: hybrid, 2020
William J. Dower   +8 more
openalex   +1 more source

Lipid-associated macrophages for osimertinib resistance and leptomeningeal metastases in NSCLC

open access: yesCell Reports
Summary: Leptomeningeal metastases (LMs) remain a devastating complication of non-small cell lung cancer (NSCLC), particularly following osimertinib resistance.
Yang-Si Li   +29 more
doaj   +1 more source

BAG2, MAD2L1, and MDK are cancer-driver genes and candidate targets for novel therapies in malignant pleural mesothelioma [PDF]

open access: hybrid
Luisa Bisceglia   +10 more
openalex   +1 more source

miR-1275 Targets MDK/AKT Signaling to Inhibit Breast Cancer Chemoresistance by Lessening the Properties of Cancer Stem Cells [PDF]

open access: green, 2021
Xu Han   +8 more
openalex   +1 more source

A novel pH-sensitive nanoparticles encapsulating anti-PD-1 antibody and MDK-siRNA overcome immune checkpoint blockade resistance in HCC via reshaping immunosuppressive TME

open access: yesJournal of Experimental & Clinical Cancer Research
Objective Immunotherapy, notably the immune checkpoint blockade (ICB), has demonstrated significant promise in the management of diverse neoplasms. However, the PD-1 inhibitor has exhibited suboptimal objective response rates and did not achieve the ...
Hai Xu   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy